| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.0027 | 1 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.0043 | 1 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |